KRAS and colorectal carcinoma: APC mutations were recently reported to be associated with a good prognosis (Mondeca et al., 2020), whereas KRAS and BRAF mutations were reported to be associated with later carcinogenesis and poor prognosis in patients with CRC (Walther et al., 2009; Pai et al., 2012).